1.Severe Mesenteric Hemorrhagic Infarction by Superior Mesenteric Arterial Occlusion in a Patient with Buerger's Disease.
Kyeong Sam OK ; You Sun KIM ; Seong Woo HONG ; Hye Kyung LEE
The Korean Journal of Gastroenterology 2013;61(4):234-236
No abstract available.
Arterial Occlusive Diseases/complications/*diagnosis/radiography
;
Hemorrhage
;
Humans
;
Ileal Diseases/radiography/surgery
;
Ileocecal Valve/blood supply
;
Infarction/pathology/*surgery
;
Male
;
Mesenteric Artery, Superior/*radiography
;
Middle Aged
;
Thromboangiitis Obliterans/complications/*diagnosis
;
Tomography, X-Ray Computed
2.A Case of Ulcerative Colitis Patient with Colonic Stenosis and Enterocutaneous Fistula.
Seong Yeon JEONG ; You Sun KIM ; Kyeong Sam OK ; Sun Ok KWON ; Jin Nam KIM ; Jeong Seop MOON ; Yun Kyung KANG ; Seong Woo HONG
Intestinal Research 2012;10(4):388-391
Ulcerative colitis (UC) is one of the chronic inflammatory bowel diseases (IBD), characterized by a diffuse mucosal inflammation limited to the colon. Complications of UC include stricture, colorectal cancer, and toxic colitis. UC patients rarely present with a stenosis or fistula, and strictures develop in less than 5% of patients with UC. We present a patient with UC, accompanied by unusual complications that involved not only a stricture but also a fistula and abscess. A 49-year-old female was presented with a left flank pain and fever that had begun two weeks before admission. She had received a diagnosis of UC 20 years ago and had it treated for 2 years in a local hospital. However, she arbitrarily stopped visiting the hospital and relied on home remedies. An abdominopelvic CT scan revealed luminal narrowing and extra-peritoneal fistula formation in the descending colon. Fistula was connected with a subcutaneous abscess in the left flank. She had undergone total colectomy and ileo-anal anastomosis. On the pathologic exam, the long standing UC with severe stenosis was observed without malignant change. It cannot be emphasized enough that a correct therapeutic approach and an appropriate follow-up schedule are very important for patients with UC.
Abscess
;
Appointments and Schedules
;
Colectomy
;
Colitis
;
Colitis, Ulcerative
;
Colon
;
Colon, Descending
;
Colorectal Neoplasms
;
Constriction, Pathologic
;
Female
;
Fever
;
Fistula
;
Flank Pain
;
Humans
;
Inflammation
;
Inflammatory Bowel Diseases
;
Intestinal Fistula
;
Medicine, Traditional
;
Middle Aged
;
Phenobarbital
;
Ulcer
3.Poria cocos ethanol extract and its active constituent, pachymic acid, modulate sleep architectures via activation of GABA(A)-ergic transmission in rats.
Vikash Kumar SHAH ; Sam Shik NA ; Myong Soo CHONG ; Jae Hoon WOO ; Yeong Ok KWON ; Mi Kyeong LEE ; Ki Wan OH
Journal of Biomedical Research 2015;16(3):84-92
Poria cocos is a well-known traditional Chinese traditional medicine (TCM) that grows around roots of pine trees in China, Korea, Japan, and North America. Poria cocos has been used in Asian countries to treat insomnia as either a single herb or part of an herbal formula. In a previous experiment, pachymic acid (PA), an active constituent of Poria cocos ethanol extract (PCE), increased pentobarbital-induced sleeping behaviors. The aim of this experiment was to evaluate whether or not PCE and PA modulate sleep architectures in rats as well as whether or not their effects are mediated through GABA(A)-ergic transmission. PCE and PA were orally administered to individual rats 7 days after surgical implantation of a transmitter, and sleep architectures were recorded by Telemetric Cortical encephalogram (EEG) upon oral administration of test drugs. PCE and PA increased total sleep time and non-rapid eye movement (NREM) sleep as well as reduced numbers of sleep/wake cycles recorded by EEG. Furthermore, PCE increased intracellular chloride levels, GAD65/67 protein levels, and alpha-, beta-, and gamma-subunits of GABA(A) receptors in primary cultured hypothalamic neuronal cells. These data suggest that PCE modulates sleep architectures via activation of GABA(A)-ergic systems. Further, as PA is an active component of PCE, they may have the same pharmacological effects.
Administration, Oral
;
Animals
;
Asian Continental Ancestry Group
;
China
;
Cocos*
;
Electroencephalography
;
Ethanol*
;
Eye Movements
;
Glutamate Decarboxylase
;
Humans
;
Japan
;
Korea
;
Medicine, Chinese Traditional
;
Neurons
;
North America
;
Pinus
;
Poria*
;
Rats*
;
Receptors, GABA-A
;
Sleep Initiation and Maintenance Disorders
4.Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
Jung Wha CHUNG ; Gi Hyun KIM ; Jong Ho LEE ; Kyeong Sam OK ; Eun Sun JANG ; Sook Hyang JEONG ; Jin Wook KIM
Clinical and Molecular Hepatology 2014;20(4):384-391
BACKGROUND/AIMS: Portal-vein thrombosis (PVT) develops in 10-25% of cirrhotic patients and may aggravate portal hypertension. There are few data regarding the effects of anticoagulation on nonmalignant PVT in liver cirrhosis. The aim of this study was to elucidate the safety, efficacy, and predictors of response to anticoagulation therapy in cirrhotic patients. METHODS: Patients with liver cirrhosis and nonmalignant PVT were identified by a hospital electronic medical record system (called BESTCARE). Patients with malignant PVT, Budd-Chiari syndrome, underlying primary hematologic disorders, or preexisting extrahepatic thrombosis were excluded from the analysis. Patients were divided into two groups (treatment and nontreatment), and propensity score matching analysis was performed to identify control patients. The sizes of the thrombus and spleen were evaluated using multidetector computed tomography. RESULTS: Twenty-eight patients were enrolled in this study between 2003 and 2014: 14 patients who received warfarin for nonmalignant PVT and 14 patients who received no anticoagulation. After 112 days of treatment, 11 patients exhibited significantly higher response rates (complete in 6 and partial in 5) compared to the control patients, with decreases in thrombus size of >30%. Compared to nonresponders, the 11 responders were older, and had a thinner spleen and fewer episodes of previous endoscopic variceal ligations, whereas pretreatment liver function and changes in prothrombin time after anticoagulation did not differ significantly between the two groups. Two patients died after warfarin therapy, but the causes of death were not related to anticoagulation. CONCLUSIONS: Warfarin can be safely administered to cirrhotic patients with nonmalignant PVT. The presence of preexisting portal hypertension is a predictor of nonresponse to anticoagulation.
Aged
;
Anticoagulants/*therapeutic use
;
Female
;
Humans
;
Liver Cirrhosis/complications/*diagnosis
;
Male
;
Middle Aged
;
Portal Vein
;
Propensity Score
;
Severity of Illness Index
;
Tomography, X-Ray Computed
;
Venous Thrombosis/complications/*drug therapy/pathology
;
Warfarin/therapeutic use
5.A Prospective Study of Factors Influencing on the Clinical Characteristics of Colonic Diverticulosis.
Sun Young KIM ; You Sun KIM ; Hyun Tae KIM ; Sun Ok KWON ; Myoung Ki OH ; In Hye CHA ; Kyeong Sam OK ; Cheol Hun KWAK ; Jin Nam KIM ; Jeong Seop MOON
The Korean Journal of Gastroenterology 2013;62(2):97-103
BACKGROUND/AIMS: The prevalence of colonic diverticulosis in Korea is increasing in conjunction with the adoption of western dietary pattern, extension of lifespan, and advances in diagnostic modalities. The clinical characteristics of colonic diverticulosis seem to be gradually becoming similar to those of Western societies. Therefore, factors associated with the clinical characteristics of colonic diverticulosis in Korea were investigated. METHODS: The data of 200 patients diagnosed with colonic diverticulosis using colonoscopy between May 2010 and April 2012 at Inje University Seoul Paik Hospital (Seoul, Korea) were prospectively collected. Clinical parameters acquired through a questionnaire include age, body mass index, waist circumference, exercise, diet, smoking, drinking habits, etc. Correlation between these factors and the clinical features of diverticulosis were analyzed. RESULTS: Mean age of the patients was 54.9+/-11.9 (range 17-79) years and male to female ratio was 2.2:1. Most diverticula were located on the right side of the colon (83%) and the mean number of diverticulum was 4.07+/-3.9. Factor associated with the location of diverticulum on the left side was age (p=0.001). There was a positive correlation between the waist circumference and the number of diverticulum (partial correlation coefficient r'=0.143, p=0.047). Diverticulitis occurred more frequently in younger patients than in older patients (p=0.002). CONCLUSIONS: Colonic diverticulosis in older patients is found more frequently on the left colon, and the number of diverticulosis is associated with central obesity.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Alcohol Drinking
;
Body Mass Index
;
Colonoscopy
;
Diverticulosis, Colonic/complications/*diagnosis/epidemiology
;
Exercise
;
Female
;
Hemorrhage/etiology
;
Humans
;
Male
;
Middle Aged
;
Prevalence
;
Prospective Studies
;
Republic of Korea/epidemiology
;
Risk Factors
;
Smoking
;
Waist Circumference
;
Young Adult
6.Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study.
Gi Hyun KIM ; Jung Wha CHUNG ; Jong Ho LEE ; Kyeong Sam OK ; Eun Sun JANG ; Jaihwan KIM ; Cheol Min SHIN ; Young Soo PARK ; Jin Hyeok HWANG ; Sook Hyang JEONG ; Nayoung KIM ; Dong Ho LEE ; Jin Wook KIM
Clinical and Molecular Hepatology 2015;21(4):379-386
BACKGROUND/AIMS: Vitamin E improves the biochemical profiles and liver histology in nonalcoholic steatohepatitis, but the role of vitamin E is not clearly defined in the management of nonalcoholic fatty liver disease (NAFLD) which includes both simple steatosis and steatohepatitis. Co-morbid metabolic syndrome increases the probability of steatohepatitis in NAFLD. In this study, we aimed to determine the short-term effects of vitamin E and off-treatment durability of response in a propensity-score matched cohort of NAFLD patients with metabolic syndrome. METHODS: A retrospective cohort was constructed by retrieving 526 consecutive NAFLD patients from the electronic medical record data warehouse of a tertiary referral hospital in South Korea. Among them, 335 patients (63.7%) had metabolic syndrome and were eligible for vitamin E therapy. In order to assess the effect of vitamin E, propensity score matching was used by matching covariates between control patients (n=250) and patients who received vitamin E (n=85). RESULTS: The PS-matched vitamin E group (n=58) and control group (n=58) exhibited similar baseline metabolic profiles. After 6 months of vitamin E therapy, the mean ALT levels decreased significantly compared to PS-matched control (P<0.01). The changes in metabolic profiles (body weight, lipid and glucose levels) did not differ between control and vitamin E groups during the study period. CONCLUSIONS: Short-term vitamin E treatment significantly reduces ALT levels in NAFLD patients with metabolic syndrome, but metabolic profiles are not affected by vitamin E.
Adult
;
Aged
;
Alanine Transaminase/blood
;
Aspartate Aminotransferases/blood
;
Body Weight
;
Cohort Studies
;
Female
;
Humans
;
Lipoproteins, HDL/blood
;
Lipoproteins, LDL/blood
;
Liver/pathology
;
Male
;
Metabolic Syndrome X/*complications/diagnosis/drug therapy
;
Middle Aged
;
Non-alcoholic Fatty Liver Disease/*complications/diagnosis/*drug therapy
;
Propensity Score
;
Republic of Korea
;
Retrospective Studies
;
Vitamin E/*therapeutic use
7.Nationwide Multicenter Study for Overlaps of Common Functional Gastrointestinal Disorders in Korean Patients With Constipation.
Kyung Sik PARK ; Sam Ryong JEE ; Bong Eun LEE ; Kyoung Sup HONG ; Jeong Eun SHIN ; Soo Young NA ; Joong Goo KWON ; Suck Chei CHOI ; Yong Sung KIM ; Hyun Seok LEE ; Tae Hee LEE ; Kyeong Ok KIM ; Jongkyoung CHOI ; Hee Seok MOON ; Yeon Soo KIM ; Moo In PARK ; Soo Jung PARK ; Seon Young PARK ; Sung Noh HONG
Journal of Neurogastroenterology and Motility 2017;23(4):569-577
BACKGROUND/AIMS: In spite of increased concerns about the overlaps among the various functional gastrointestinal disorders (FGIDs), studies for the overlap between constipation and other common FGIDs are rare. Therefore, we investigated the patterns of overlaps between constipation and other common FGIDs. METHODS: This study was designed as a prospective nationwide multi-center questionnaire study using Rome III questionnaires for functional dyspepsia (FD), irritable bowel syndrome (IBS), and functional constipation (FC), as well as various questionnaires about patients’ information, degree of symptoms, and quality of life. For the evaluation of gastroesophageal reflux disease (GERD), GERD-Q was used. RESULTS: From 19 centers, 759 patients with constipation were enrolled. The proportions of FC and IBS subtypes of constipation (IBS-C) were 59.4% and 40.6%, respectively. Among them, 492 (64.8%) showed no overlap. One hundred and thirty-six patients (17.9%) presented overlapping GERD, and 80 patients (10.5%) presented overlapping FD. Fifty one (6.7%) of patients were overlapped by both GERD and FD. Coincidental herniated nucleus pulposus (HNP) (P = 0.026) or pulmonary diseases (P = 0.034), reduced fiber intake (P = 0.013), and laxative use (P < 0.001) independently affected the rate of overlaps. These overlapping conditions negatively affected the constipation-associated quality of life, general quality of life, and degree of constipation. CONCLUSIONS: The overlap of GERD or FD was common in patients with constipation. Coincidental HNP or pulmonary diseases, reduced fiber intake, and laxatives use were found to be independent associated factors for overlapping common FGIDs in Korean patients with constipation.
Constipation*
;
Dyspepsia
;
Gastroesophageal Reflux
;
Gastrointestinal Diseases*
;
Humans
;
Irritable Bowel Syndrome
;
Laxatives
;
Lung Diseases
;
Prospective Studies
;
Quality of Life
8.1991 cancer incidence in Seoul, Korea: results of the Implementation Study of the Seoul Cancer Registry.
Jin Pok KIM ; In Seo PARK ; Yoon Ok AHN ; Myung Hee SHIN ; Don Hee AHN ; Tae Woong KANG ; Ung Ring KO ; Pyong Sahm KU ; Kwang Yun KIM ; Kwang Hyun KIM ; Noe Kyeong KIM ; Dong Jip KIM ; Doo Ho KIM ; Byung Soo KIM ; Sang Hee KIM ; Chong Taik PARK ; Jin Sik MIN ; Tchan Kyu PARK ; Bock Hi WOO ; Hee YOO ; Sang Woong LEE ; Sang Jae LEE ; Kyung Sam CHO ; Hoong Zae JOO ; Eui Keun HAM
Journal of Korean Medical Science 1995;10(2):74-84
This article presents the results of the Implementation Study of the Seoul Cancer Registry, which started in July, 1991 as a population based cancer registry in Seoul, Korea. The completeness and validity of the registered data were evaluated using Mortality/Incidence ratio (M/I ratio), Histologically Verified Cases (HV%), Primary Site Uncertain (PSU%), and Age Unknown (Age UNK%). Owing to the additional active surveillance, the completeness of the data turned out to be fairly acceptable, except for the aged over 75(Mortality/Incidence ratio was over 100%). Eventhough the Seoul cancer registry(SCR) has further way to go in the completeness especially among elderly persons, the validity of SCR data was also acceptable in terms of HV%, PSU%, and Age UNK%. However, PSU% and Age UNK% might need to be further reduced to be comparable with other well established cancer registries. The age standardized incidence rates(ASR) of all cancers between July 1, 1991 and June 30, 1992 were 232.4/100,000 in males and 147.9/100,000 in females. The top five major sites of cancers in Seoul were the stomach, liver, lung, colo-rectum, and bladder in order in males, and the uterine cervix, stomach, breast, colo-rectum, and liver in females. Those 5 cancer sites comprised 68.9% and 64.7% of the total cancer incidence in males and females, respectively.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Child
;
Child, Preschool
;
Female
;
Human
;
Incidence
;
Infant
;
Korea/epidemiology
;
Male
;
Middle Age
;
Neoplasms/*epidemiology/pathology
;
*Registries
;
Sex Factors
;
Support, Non-U.S. Gov't